Abstract
Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Current HIV Research
Title: Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression
Volume: 8 Issue: 6
Author(s): Carmen Torres, Manuel Sanchez-de-la-Torre, Carelia Garcia-Moruja, Antonio Jose Carrero, Maria del Monte Trujillo, Joan Fibla and Antonio Caruz
Affiliation:
Keywords: Vitamin-D-receptor, rs1544410, dendritic cells, HIV-1, CD209, CD14, LTR
Abstract: Vitamin-D-receptor (VDR) mediates immunomodulatory effects of vitamin-VD3 (VD3). The VDRrs1544410_ GG polymorphism has been associated with delayed progression rates to AIDS and resistance to HIV-1 infection. The aim of the present study was to investigate differences in VD3 mediated effects on rs1544410 genotyped dendritic cells (DCs) and macrophages (MDM), key cells involved in HIV-1 infection. Immature DCs exhibited lower bactin- normalized VDR mRNA expression in rs1544410_GG compared to cells with a rs1544410_AA genotype. VD3 response on cell differentiation markers (CD14 inhibition and CD209 induction) was two-fold higher in rs1544410_AA (CD209, p=0.012; CD14, p=0.02). HIV-1-LTR reporter gene activity in MDM was boosted by VD3 ; however, the effect was up to 50% higher in rs1544410_AA. We conclude that the rs1544410_AA association with progression to AIDS and resistance to HIV-1 appears to be linked to an enhanced response to VD3.
Export Options
About this article
Cite this article as:
Torres Carmen, Sanchez-de-la-Torre Manuel, Garcia-Moruja Carelia, Carrero Jose Antonio, Trujillo del Monte Maria, Fibla Joan and Caruz Antonio, Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression, Current HIV Research 2010; 8 (6) . https://dx.doi.org/10.2174/157016210793499330
DOI https://dx.doi.org/10.2174/157016210793499330 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design Inhibitors of the Metalloproteinase Anthrax Lethal Factor
Current Topics in Medicinal Chemistry Editorial
Current Medicinal Chemistry Atherosclerosis and Inflammation: Insight from Carotid and Intracoronary Ultrasound Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research
Current Medicinal Chemistry Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs
Current Drug Targets - Infectious Disorders Neuroimaging of Gut Nutrient Perception
Current Pharmaceutical Design Small Peptide Radiopharmaceuticals in the Imaging of Acute Thrombus
Current Pharmaceutical Design The Case of Biotech-Derived Product Equivalence: Much Ado About Nothing?
Current Clinical Pharmacology Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Metabolomics and Its Practical Value in Pharmaceutical Industry
Current Drug Metabolism Anti-Cytokine Therapeutics: History and Update
Current Pharmaceutical Design Point-of-Care Genetic Tests for Infectious Disease: Legal Considerations
Current Pharmacogenomics and Personalized Medicine Anti-Angiogenic Therapy in Renal Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Synthesis of Benzophenonehydrazone Schiff Bases and their In Vitro Antiglycating Activities
Medicinal Chemistry CD31+ Circulating Angiogenic Cell Number and Subtypes are Reduced in Individuals with Chronic Stroke
Current Neurovascular Research New Developments in Molecular Diagnosis of Bacteremic Pneumococcal Pneumonia
Current Respiratory Medicine Reviews Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
Current Medicinal Chemistry